According to a consensus view, increased levels of PrPc endow CSCs with self-renewal, proliferative [65,66,67], migratory, and invasive capacities [21,23,68], along with increased resistance to anti-cancer agents [30,31,69]. The gene discussed is PRNP; the disease is cancer.